Search Results

There are 2524898 results for: content related to: Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression

  1. Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats

    Hippocampus

    Volume 17, Issue 8, August 2007, Pages: 627–633, Bernat Kocsis, Shaomin Li and Mihaly Hajos

    Article first published online : 9 MAY 2007, DOI: 10.1002/hipo.20299

  2. You have free access to this content
    The Selective Norepinephrine Reuptake Inhibitor Antidepressant Reboxetine: Pharmacological and Clinical Profile

    CNS Drug Reviews

    Volume 10, Issue 1, March 2004, Pages: 23–44, Mihály Hajós, Joseph C. Fleishaker, Jacqueline K. Filipiak-Reisner, Mark T. Brown and Erik H. F. Wong

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00002.x

  3. You have free access to this content
    Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 389–398, Neil Benson, Nelleke Snelder, Bart Ploeger, Carolyn Napier, Harriet Sale, Nigel JM Birdsall, Richard P Butt and Piet H van der Graaf

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00719.x

  4. Paroxetine versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Marianna Purgato, Davide Papola, Chiara Gastaldon, Carlotta Trespidi, Laura R Magni, Carla Rizzo, Toshi A Furukawa, Norio Watanabe, Andrea Cipriani and Corrado Barbui

    Published Online : 3 APR 2014, DOI: 10.1002/14651858.CD006531.pub2

  5. You have free access to this content
    The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy

    Epilepsia

    Volume 53, Issue 5, May 2012, Pages: 870–878, Katia Vermoesen, Ann Massie, Ilse Smolders and Ralph Clinckers

    Article first published online : 16 MAR 2012, DOI: 10.1111/j.1528-1167.2012.03436.x

  6. Reboxetine, a selective noradrenaline reuptake inhibitor, is non-sedative and does not impair psychomotor performance in healthy subjects

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue 6, August 1998, Pages: 425–433, Werner M. Herrmann and Hermann Fuder

    Article first published online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199808)13:6<425::AID-HUP17>3.0.CO;2-R

  7. Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue S1, February 1998, Pages: S29–S39, T. A. Ban, P. Gaszner, E. Aguglia, R. Batista, A. Castillo, A. Lipcsey, J.-P. Macher, A. Torres-Ruiz and L. Vergara

    Article first published online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.0.CO;2-D

  8. You have free access to this content
    The Promises and Pitfalls of Reboxetine

    CNS Drug Reviews

    Volume 9, Issue 4, December 2003, Pages: 327–342, Michelle E. Page

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2003.tb00258.x

  9. You have free access to this content
    Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize α2-adrenoceptors in the prefrontal cortex

    British Journal of Pharmacology

    Volume 132, Issue 1, January 2001, Pages: 183–188, R W Invernizzi, S Parini, G Sacchetti, C Fracasso, S Caccia, K Annoni and R Samanin

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703821

  10. Separation of reboxetine enantiomers by means of capillary electrophoresis

    ELECTROPHORESIS

    Volume 23, Issue 12, No. 12 June 2002, Pages: 1870–1877, Maria A. Raggi, Roberto Mandrioli, Cesare Sabbioni, Carlo Parenti, Giuseppe Cannazza and Salvatore Fanali

    Article first published online : 2 JUL 2002, DOI: 10.1002/1522-2683(200206)23:12<1870::AID-ELPS1870>3.0.CO;2-R

  11. You have free access to this content
    Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

    British Journal of Pharmacology

    Volume 128, Issue 6, November 1999, Pages: 1332–1338, G Sacchetti, M Bernini, A Bianchetti, S Parini, R W Invernizzi and R Samanin

    Article first published online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0702926

  12. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

    European Journal of Neuroscience

    Volume 13, Issue 11, June 2001, Pages: 2077–2087, Steven T. Szabo and Pierre Blier

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.0953-816x.2001.01583.x

  13. Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 1, January 1999, Pages: 53–57, Joseph C. Fleishaker, Massimiliano Mucci, Cinzia Pellizzoni and Italo Poggesi

    Article first published online : 14 APR 1999, DOI: 10.1002/(SICI)1099-081X(199901)20:1<53::AID-BDD157>3.0.CO;2-P

  14. The need for new and better antidepressants: reboxetine a new option

    Acta Psychiatrica Scandinavica

    Volume 101, Issue s402, June 2000, Pages: 6–11, Sven J. Dencker

    Article first published online : 22 OCT 2003, DOI: 10.1034/j.1600-0447.2000.02602.x

  15. Reboxetine: tolerability and safety profile in patients with major depression

    Acta Psychiatrica Scandinavica

    Volume 101, Issue s402, June 2000, Pages: 37–40, Lars Tanum

    Article first published online : 22 OCT 2003, DOI: 10.1034/j.1600-0447.2000.02606.x

  16. Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography

    Synapse

    Volume 66, Issue 11, November 2012, Pages: 923–930, Adriana Alexandre S. Tavares, Nicola K. Jobson, Deborah Dewar, Andrew Sutherland, Sally L. Pimlott, Jeffery Batis, Olivier Barret, John Seibyl and Gilles Tamagnan

    Article first published online : 30 JUL 2012, DOI: 10.1002/syn.21585

  17. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

    Human Psychopharmacology: Clinical and Experimental

    Volume 21, Issue 5, July 2006, Pages: 337–345, Cengiz Akkaya, Enver Yusuf Sivrioglu, Semra Akgoz, Salih Saygin Eker and Selcuk Kirli

    Article first published online : 20 JUL 2006, DOI: 10.1002/hup.770

  18. You have free access to this content
    Differential α2-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade

    Journal of Neurochemistry

    Volume 98, Issue 1, July 2006, Pages: 113–121, V. Valentini, F. Cacciapaglia, R. Frau and G. Di Chiara

    Article first published online : 12 MAY 2006, DOI: 10.1111/j.1471-4159.2006.03851.x

  19. Citalopram versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe and Corrado Barbui

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD006534.pub2

  20. Pharmacokinetics of Single-Dose Reboxetine in Volunteers with Renal Insufficiency

    The Journal of Clinical Pharmacology

    Volume 40, Issue 5, May 2000, Pages: 482–487, Dr. François Coulomb, Dr. Francis Ducret, Mr. Jean-Paul Laneury, Dr. Francesco Fiorentini, Dr. Italo Poggesi, Dr. M. Gabriella Jannuzzo, Dr. Joseph C. Fleishaker, Dr. Georges Houin and Dr. Patrick Duchêne

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912700022009251